Compare Stocks: FLGC, FEMY, ICU, and IRIX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$1.37 -2.8%	$2.36	$1.32 ▼ $22.20	N/A	N/A	N/A	228,771 shs
FLGC Flora Growth	$3.13 -4.6%	$4.46	$5.86 ▼ $47.00	$3.27M	1.9	39,454 shs	8,707 shs
ICU SeaStar Medical	$2.52 +2.0%	$3.25	$2.07 ▼ $6.00	N/A	N/A	N/A	76,742 shs
IRIX IRIDEX	$0.74 -1.8%	$0.72	$0.61 ▼ $1.65	N/A	N/A	N/A	29,553 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	-6.00%	-13.50%	-43.15%	-51.71%	-88.87%
FLGC Flora Growth	0.00%	-18.00%	-19.41%	+130.99%	-75.34%
ICU SeaStar Medical	+2.49%	-20.58%	-27.78%	-28.20%	-59.76%
IRIX IRIDEX	+1.11%	-2.08%	+20.64%	-14.43%	-31.45%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$1.37 -2.8%	$2.36	$1.32 ▼ $22.20	N/A	N/A	N/A	228,771 shs
FLGC Flora Growth	$3.13 -4.6%	$4.46	$5.86 ▼ $47.00	$3.27M	1.9	39,454 shs	8,707 shs
ICU SeaStar Medical	$2.52 +2.0%	$3.25	$2.07 ▼ $6.00	N/A	N/A	N/A	76,742 shs
IRIX IRIDEX	$0.74 -1.8%	$0.72	$0.61 ▼ $1.65	N/A	N/A	N/A	29,553 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	-6.00%	-13.50%	-43.15%	-51.71%	-88.87%
FLGC Flora Growth	0.00%	-18.00%	-19.41%	+130.99%	-75.34%
ICU SeaStar Medical	+2.49%	-20.58%	-27.78%	-28.20%	-59.76%
IRIX IRIDEX	+1.11%	-2.08%	+20.64%	-14.43%	-31.45%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEMY Femasys	2.50	Moderate Buy	$50.00	3,549.64% Upside
FLGC Flora Growth	1.00	Sell	N/A	N/A
ICU SeaStar Medical	2.00	Hold	$8.00	217.46% Upside
IRIX IRIDEX	2.00	Hold	$3.00	305.30% Upside

Current Analyst Ratings Breakdown

Latest FLGC, FEMY, ICU, and IRIX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/20/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/15/2026	ICU SeaStar Medical	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
10/2/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/18/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
9/4/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/21/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/18/2026	FEMY Femasys	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$10.00
8/17/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	FEMY Femasys	Maxim Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$10.00
8/6/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
7/31/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 10/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEMY Femasys	N/A	N/A	N/A	N/A	N/A	N/A
FLGC Flora Growth	$57.61M	0.06	N/A	N/A	$12.21 per share	0.26
ICU SeaStar Medical	N/A	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEMY Femasys	N/A	-$3.53	N/A	N/A	N/A	N/A	N/A	N/A	11/17/2026 (Estimated)
FLGC Flora Growth	-$15.91M	-$32.49	N/A	N/A	N/A	-32.03%	-64.02%	-34.46%	N/A
ICU SeaStar Medical	N/A	-$3.91	N/A	N/A	N/A	N/A	N/A	N/A	11/12/2026 (Estimated)
IRIX IRIDEX	N/A	-$0.20	N/A	N/A	N/A	N/A	N/A	N/A	11/17/2026 (Estimated)

Latest FLGC, FEMY, ICU, and IRIX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/17/2026	Q3 2026	FEMY Femasys	-$0.47	N/A	N/A	N/A	$0.76 million	N/A
11/17/2026	Q3 2026	IRIX IRIDEX	-$0.04	N/A	N/A	N/A	$12.65 million	N/A
11/12/2026	Q3 2026	ICU SeaStar Medical	-$0.95	N/A	N/A	N/A	$0.50 million	N/A
8/18/2026	Q2 2026	IRIX IRIDEX	-$0.01	-$0.07	-$0.06	-$0.07	$13.59 million	$12.57 million
8/14/2026	Q2 2026	FEMY Femasys	-$1.31	-$1.33	-$0.02	-$1.33	$0.73 million	$0.33 million
8/12/2026	Q2 2026	ICU SeaStar Medical	-$0.97	-$0.91	+$0.06	-$0.91	$0.49 million	$0.62 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
FLGC Flora Growth	N/A	N/A	N/A	N/A	N/A
ICU SeaStar Medical	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEMY Femasys	N/A	N/A	N/A
FLGC Flora Growth	N/A	2.08	1.79
ICU SeaStar Medical	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FEMY Femasys	65.27%
FLGC Flora Growth	36.01%
ICU SeaStar Medical	1.69%
IRIX IRIDEX	20.10%

Insider Ownership

Company	Insider Ownership
FEMY Femasys	7.75%
FLGC Flora Growth	2.34%
ICU SeaStar Medical	0.70%
IRIX IRIDEX	8.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FEMY Femasys	54	N/A	7.73 million	Not Optionable
FLGC Flora Growth	280	1.05 million	1.02 million	Not Optionable
ICU SeaStar Medical	17	N/A	4.38 million	Not Optionable
IRIX IRIDEX	108	N/A	16.05 million	Optionable

FLGC, FEMY, ICU, and IRIX Headlines

Recent News About These Companies

IRIDEX (NASDAQ:IRIX) Stock Price Breaks Below 200-Day Moving Average - Here's What Happened

October 20, 2026 | americanbankingnews.com

Iridex Reports Sustained Glaucoma Benefits With MicroPulse Laser Therapy At Two Years

October 12, 2026 | rttnews.com

Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use

October 12, 2026 | finance.yahoo.com

Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma

October 12, 2026 | marketscreener.comM

IRIDEX (NASDAQ:IRIX) Major Shareholder Buys 10,000 Shares of Company Stock

October 8, 2026 | insidertrades.com

IRIDEX reports lower revenue: what it means for IRIX stock

October 5, 2026 | ad-hoc-news.deA

Iridex Completes Relocation of Manufacturing Facility to San Jose, California

October 5, 2026 | globenewswire.com

IRIDEX Corporation stock trades near its yearly low

September 23, 2026 | ad-hoc-news.deA

Iridex stock holds steady as investors await next update

September 19, 2026 | ad-hoc-news.deA

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%

August 25, 2026 | zacks.com

Iridex: Q2 Earnings Snapshot

August 18, 2026 | chron.com

Iridex reaffirms 2026 revenue guidance of $51m-$53m while highlighting working-capital build tied to headquarters relocation

August 18, 2026 | seekingalpha.com

IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript

August 18, 2026 | seekingalpha.com

Iridex Reports Second Quarter 2026 Financial Results

August 18, 2026 | globenewswire.com

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

August 4, 2026 | globenewswire.com

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

July 20, 2026 | globenewswire.com

Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference

June 9, 2026 | globenewswire.com

IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth

May 25, 2026 | zacks.com

IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

May 20, 2026 | finance.yahoo.com

IRIDEX Corporation (NASDAQ:IRIX) Q1 2026 Earnings Call Transcript

May 20, 2026 | insidermonkey.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

FLGC, FEMY, ICU, and IRIX Company Descriptions

Femasys NASDAQ:FEMY

$1.37 -0.04 (-2.84%)

Closing price 04:00 PM Eastern

Extended Trading

$1.37 0.00 (0.00%)

As of 07:30 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Flora Growth NASDAQ:FLGC

$3.13 -0.15 (-4.57%)

As of 10/26/2026

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

SeaStar Medical NASDAQ:ICU

$2.52 +0.05 (+2.02%)

Closing price 04:00 PM Eastern

Extended Trading

$2.49 -0.03 (-1.07%)

As of 07:55 PM Eastern

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

IRIDEX NASDAQ:IRIX

$0.74 -0.01 (-1.83%)

Closing price 04:00 PM Eastern

Extended Trading

$0.76 +0.02 (+3.22%)

As of 07:41 PM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FLGC, FEMY, ICU, and IRIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FLGC, FEMY, ICU, and IRIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FLGC, FEMY, ICU, and IRIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

FLGC, FEMY, ICU, and IRIX Company Descriptions

Femasys NASDAQ:FEMY

Flora Growth NASDAQ:FLGC

SeaStar Medical NASDAQ:ICU

IRIDEX NASDAQ:IRIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FLGC, FEMY, ICU, and IRIX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FLGC, FEMY, ICU, and IRIX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FLGC, FEMY, ICU, and IRIX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

FLGC, FEMY, ICU, and IRIX Company Descriptions

Femasys NASDAQ:FEMY

Flora Growth NASDAQ:FLGC

SeaStar Medical NASDAQ:ICU

IRIDEX NASDAQ:IRIX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools